|BIBCL -- India Stock|| |
INR 8.70 0.30 3.33%
The Macroaxis Fundamental Analysis lookup allows users to check a given indicator for any equity or select from a set of available indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations. Please check also Equity Screeners
to view more equity screening tools
Bharat Immunologicals Current Ratio Analysis
Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Bharat Immunologicals ValuationFundamentalsBuy or Sell
|Bharat Immunologicals ||Current Ratio|| = |
About Current Ratio
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e. Current Ration of 2 to 1).
In accordance with recently published financial statements Bharat Immunologicals Biologicals Corp Ltd has Current Ratio of 1.79 times. This is 38.49% lower than that of the Healthcare sector, and 70.99% lower than that of Biotechnology
industry, The Current Ratio for all stocks is 45.76% higher than the company.
Bharat Immunologicals Fundamental Drivers Relationships
Bharat Immunologicals Biologicals Corp Ltd is rated below average
in return on equity category among related companies. It is rated below average
in profit margin category among related companies .